Cambridge Consultants has reinvested in gene synthesis platform developer Evonetix, helping it increase its lifetime funding to $46m.

The immuno-oncology therapy developer has raised a sliver over $100m, Takeda Ventures leading a round that included M Ventures, Ipsen Ventures and MRL Ventures Fund.

Returning investor Lloyds contributed to a round that will support the banking software provider's ongoing growth in the Asia Pacific region.

Woowa Brothers and Rakuten Capital contributed to a series B round for Southeast Asian online food ordering service Dahmakan.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Prefab home provider Veev confirmed it has raised a total of $85m in equity funding from investors including Lennar Ventures, on top of $12m in debt financing.

Cyagen's Chinese research product spinoff raised $40.5m and will use the funding to grow its business along with its contract research services.

Stem cell medicine and skincare product developer has added $12.5m as part of a series B-2 round that will come after $15m from SFC two years ago.

The no-code app development platform has raised a further $51m in a second tranche led by CapitalG, the corporate that also backed its first close in October.

The record-digitisation technology provider has now disclosed nearly $120m in financing altogether, strategic partner CDK Global leading its latest round.